You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昂利康(002940.SZ)擬向江蘇悦新增資1.1億元
格隆匯 08-24 12:14

格隆匯8月24日丨昂利康(002940.SZ)公佈,公司於2019年8月22日召開第二屆董事會第十一次會議,審議通過了《關於使用自有資金向全資子公司江蘇悦新藥業有限公司增資的議案》,同意公司使用自有資金1.1億元人民幣對全資子公司江蘇悦新藥業有限公司(“江蘇悦新”)進行增資,增資完成後江蘇悦新註冊資本變更為1.6億元人民幣,仍為公司全資子公司。

江蘇悦新藥業有限公司經營範圍:化工產品製造[7-氨基去乙酰氧基頭孢烷酸、卡馬環合物(2,2ˊ-二硝基二苯乙烷)、頭孢克羅、磷酸伯氨喹、頭孢氨苄、過乙酸[含量≤43%,含水≥5%,含乙酸≥35%,含過氧化氫≤6%,含有穩定劑]、吡啶、硫酸鈉、硫酸銨、醋酸鈉、苯乙酸、芒硝],自營和代理各類商品和技術的進出口業務(國家限定企業經營或禁止進出口的商品和技術除外)。(依法須經批准的項目,經相關部門批准後方可開展經營活動)

公司此次對上述全資子公司進行增資,是基於公司發展戰略和子公司的經營發展需要,有利於未來將江蘇悦新打造成為公司重要的原料藥生產基地,將進一步提高公司的綜合競爭力。

此次增資資金來源為公司自有資金,不會對公司財務及經營狀況產生不利影響,也不會導致公司合併報表範圍發生變化,符合公司發展戰略,不存在損害公司及全體股東合法利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account